SNPHY (SNPHY) Stock Price & Analysis
SNPHY (SNPHY) rose 1.41% to USD 12.2 as of June 10, 2026 at 03:33 UTC, according to Nexqual real-time market data.
SNPHY last closed at USD 12.03; the session ranged USD 12.2–12.2 on volume of 400 shares. Market capitalization is $3.92B, with a 52-week range of USD 9.22–12.68 (PNK). Source: Nexqual, June 10, 2026 at 03:33 UTC.
Key Statistics (as of June 10, 2026 at 03:33 UTC)
| Price | USD 12.2 |
|---|---|
| Change | ▲ 1.41% (up) |
| Previous Close | USD 12.03 |
| Open | USD 12.2 |
| Day Range | USD 12.2 – 12.2 |
| 52-Week Range | USD 9.22 – 12.68 |
| Volume | 400 shares |
| Market Cap | $3.92B |
| Exchange | PNK |
Technical Analysis (SNPHY)
Nexqual's technical model rates SNPHY "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 03:33 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 58.56 (neutral) |
| vs SMA50 | Above (USD 11.35) |
| MACD | 0.24 (positive) |
Analyst Ratings (SNPHY)
Wall Street analysts rate SNPHY "None", per Nexqual as of June 10, 2026 at 03:33 UTC.
| Consensus Rating | None |
|---|
Earnings (SNPHY)
| Revenue Estimate | $70.46B |
|---|
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Financials & Fundamentals (SNPHY)
| Total Revenue | $291.62B |
|---|---|
| Revenue Growth (YoY) | +4.70% |
| Gross Margin | +58.21% |
| Operating Margin | +24.21% |
| Profit Margin | +12.81% |
| ROE | +12.93% |
| Current Ratio | 2.6 |
| Total Cash | $80.88B |
| Total Debt | $0 |
| Free Cash Flow | $21.41B |
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Financial Health Score (SNPHY)
Nexqual rates SNPHY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 03:33 UTC.
| Growth | Strong — Revenue +55% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 58%, operating 24% |
| Balance Sheet | Mixed — $80.9B cash, no debt |
| Cash Flow | Solid — FCF $21.4B, 7% margin |
| Efficiency | Mixed — ROE 13%, ROA 7.2% |
Ownership (SNPHY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 321.68M |
| Float | 321.68M |
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Leadership (SNPHY)
SNPHY is led by Takeshi Ito (age 66), President, CEO & Representative Director, per Nexqual as of June 10, 2026 at 03:33 UTC.
| President, CEO & Representative Director | Takeshi Ito (age 66) |
|---|---|
| CFO & Corporate Officer | Kazuo Koshiji |
| COO, Corporate Officer & Director | Rie Nakajima (age 48) |
Major Backers & Investors (SNPHY)
Notable institutional backers of SNPHY include WisdomTree Trust-WisdomTree Japan Hedged Equity Fund, according to Nexqual as of June 10, 2026 at 03:33 UTC.
Active Investors
| Investor | Stake |
|---|---|
| WisdomTree Trust-WisdomTree Japan Hedged Equity Fund | 0.12% |
Source: Nexqual, June 10, 2026 at 03:33 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
| SSMXY | Sysmex Corp. | USD 9.04 | ▼ 1.53% |
| RYKKY | Ryohin Keikaku Co. Ltd. | USD 10.8 | ▼ 0.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:33 UTC. This page is informational and not investment advice.